Bicycle Therapeutics Plc share price logo

Bicycle Therapeutics Plc Share Price

NASDAQ: BCYC

Small Cap

$4.31

-0.04

(-0.92%)

Live

as on

Bicycle Therapeutics Plc Stock Performance

as on March 24, 2026 at 1:10 am IST

  • Day's Low

    Day's High

    $4.25
    $4.50
    downward going graph

    1.39%

    Downside

    4.41%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $4.30
    $9.69
    downward going graph

    0.35%

    Downside

    124.83%

    Upside

    downward going graph

Bicycle Therapeutics Plc share price movements today

Previous Close
$4.35
Open
$4.50
Volume
124.0K
Day's Low - High
$4.25 - $4.50
52 Week Low - High
$4.30 - $9.69

Bicycle Therapeutics Plc Historical Returns

1 Month Return
-20.04 %
3 Month Return
-37.32 %
1 Year Return
-52.09 %
3 Year Return
-78.62 %
5 Year Return
-82.76 %

Bicycle Therapeutics Plc Stock Fundamentals & Key Indicators

Check Bicycle Therapeutics Plc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$301.8M

EPS (TTM)

-2.225

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-6.22

Industry PE ratio

-4.738881355932204

PEG Ratio

0

EBITDA

-236.4M

Revenue (TTM)

72.6M

Profit Margin

0.00%

Return On Equity TTM

-31.21%

Bicycle Therapeutics Plc Stock Valuation

Track how Bicycle Therapeutics Plc P/E has moved over time to understand its valuation trends.

Bicycle Therapeutics Plc in the last 5 years

  • Overview

  • Trends

Lowest (-20.51x)

December 31, 2021

Today (-6.22x)

March 23, 2026

Industry (-4.74x)

March 23, 2026

Highest (-2.05x)

September 30, 2025

LowHigh

Today’s Price to Earnings Ratio: -6.22x

Bicycle Therapeutics Plc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Bicycle Therapeutics Plc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Bicycle Therapeutics Plc image
Bicycle Therapeutics Plc
BUY$301.8M-82.76%-6.220.00%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$41.4B125.13%133.418.45%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$115.3B112.56%29.6732.94%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$31.6BNA1115.37%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$77.5B56.01%17.6731.41%

Stock Returns calculator for Bicycle Therapeutics Plc Stock including INR - Dollar returns

The Bicycle Therapeutics Plc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Bicycle Therapeutics Plc investment value today

Current value as on today

₹57,386

Returns

₹42,614

(-42.61%)

Returns from Bicycle Therapeutics Plc Stock

₹52,533 (-52.53%)

Dollar Returns*

₹9,919 (+9.92%)

Analyst Recommendation on Bicycle Therapeutics Plc Stock

Based on 18 analysts

BUY

88.89%

Buy

11.11%

Hold

0.00%

Sell

Based on 18 analysts, 88.89% of analysts recommend a 'BUY' rating for Bicycle Therapeutics Plc. Average target price of $15.1

Bicycle Therapeutics Plc Share Price Target

Get share price movements and forecasts by analysts on Bicycle Therapeutics Plc.

What analysts predicted

71.46%UPSIDE

Target Price

$15.1

Current Price

$4.31

Analyzed by

18 Analysts

Target

$15.10

Bicycle Therapeutics Plc target price $15.1, a slight upside of 71.46% compared to current price of $4.31. According to 18 analysts rating.

Bicycle Therapeutics Plc Stock’s Investor Sentiment and Interest

Search interest for Bicycle Therapeutics Plc Stock has increased by 71% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:71% versus previous 30 day period

Bicycle Therapeutics Plc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
5
5
19
9
2
3
9
2
11
47
Gross Profit
5
5
19
9
-42
-52
-47
-68
11
12
Operating Income
-50
-54
-31
-46
-63
-67
-70
-86
-65
-60
EBITDA
-45
-46
-24
-37
-61
-65
-70
-77
-57
-29
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
1
1
1
1
2
1
1
1
1
1
Income Before Tax
-47
-48
-26
-39
-54
-52
-61
-79
-58
-54
Income Tax Expense
2
0
0
0
-3
-1
-1
0
0
-5
Net Income
-49
-49
-26
-39
-50
-51
-60
-78
-59
-20
Net Profit Margin
-932.32%
-921.01%
-136.01%
-425.30%
-1898.43%
-1398.44%
-608.94%
-2703.84%
-503.66%
-42.03%

Bicycle Therapeutics Plc Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
2
7
13
10
11
14
26
35
72
Gross Profit
0
-9
-13
13
-22
11
14
-129
-137
66
Operating Income
-13
-16
-21
-26
-51
-65
-116
-189
-209
-283
EBITDA
-13
-15
-21
-25
-50
-64
-107
-183
-164
-276
Interest Expense
-
-
-
3
0
2
3
3
1
0
Depreciation
-
0
0
0
1
1
3
6
7
6
Income Before Tax
-13
-16
-22
-30
-51
-68
-114
-179
-173
-254
Income Tax Expense
0
0
0
0
0
-1
-1
1
-4
-34
Net Income
-13
-16
-21
-30
-51
-66
-112
-180
-169
-218
Net Profit Margin
0.00%
-789.27%
-306.14%
-221.78%
-490.95%
-571.25%
-779.35%
-669.72%
-479.18%
-301.66%

Bicycle Therapeutics Plc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-49
-26
-39
-51
-51
-60
-78
-59
-19
Operating Cash Flow
-47
-70
-44
-39
-9
-86
-72
-71
-19
Investing Cash Flow
0
0
0
0
0
0
0
0
0
Financing Cash Flow
0
1
549
-31
0
0
0
0
0
Change in Cash
-45
-69
504
-70
-11
-86
-71
-73
-19

Bicycle Therapeutics Plc Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-16
-21
-30
-51
-66
-112
-180
-169
-218
Operating Cash Flow
-1
-26
-28
-17
-14
-86
-60
-164
-249
Investing Cash Flow
-1
-1
-1
-1
-2
-18
-2
-1
-2
Financing Cash Flow
57
25
58
62
320
6
250
519
0
Change in Cash
58
-4
28
43
302
-99
187
353
-251

Global Institutional Holdings in Bicycle Therapeutics Plc

Funds
Holdings
Bank of America Corp
0.85%
Silvercrest Asset Management Group LLC
0.69%
Westfield Capital Management Company, L.P.
4.35%
BNP Paribas Investment Partners SA
1.5%
Long Focus Capital Management, LLC
2.35%
See all

Insights on Bicycle Therapeutics Plc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, -78.95M → -20.15M (in $), with an average increase of 113.4% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 3 quarters, 2.92M → 47.95M (in $), with an average increase of 75.3% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Regeneron Pharmaceuticals, Inc. has given 11.3% return, outperforming this stock by 63.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Bicycle Therapeutics Plc has experienced a drawdown of -78.6%, however Alnylam Pharmaceuticals, Inc. resisted the overall trend and outperformed by 70.0%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, BCYC stock has moved down by -13.9%

About Bicycle Therapeutics Plc

bicycle therapeutics is a biotechnology company with big ambitions. we aim to revolutionise the pharmaceutical landscape with our disruptive technology and proprietary bicyclic peptide (bicycle®) product platform and to develop transformational new therapies for patients to improve future treatment options in oncology. bicycles, a new class of small molecular weight drug conjugates for oncology and other diseases, are designed to have superior targeting abilities and to be more efficacious and better tolerated than existing drug conjugate modalities. they combine the properties of several therapeutic entities in a single modality, exhibiting the affinity and selective pharmacology associated with antibodies; the distribution kinetics of small molecules, allowing rapid tumor penetration; and the “tuneable” pharmacokinetic half-life and renal clearance of peptides, sparing cytotoxin-payload derived liver and gastrointestinal toxicity. our unique ip is based on the work of scientific foun
OrganisationBicycle Therapeutics Plc
HeadquartersPortway Building, Cambridge, United Kingdom, CB21 6GS
IndustryBiotechnology
CEODr. Kevin Lee M.B.A., Ph.D.
E-voting on sharesClick here to vote

Key Management of Bicycle Therapeutics Plc

Name

Title

Mr. Travis Thompson

Chief Financial Officer

Dr. Michael Skynner B.sc. Ph.d., Ph.D.

Chief Scientific Officer

Ms. Stephanie Yao

Senior Vice President of Investor Relations and Corporate Communications

Dr. Christian Heinis

Scientific Founder

Ms. Jennifer Perry Pharm.D.

Chief Operating Officer

Mr. Zafar Qadir

Chief Legal Officer & General Counsel

Dr. Gillian Langford Ph.D.

Head of Clinical and Project Management

Dr. Kevin Lee M.B.A., Ph.D.

CEO & Executive Director

Mr. Alistair Milnes

Chief Corporate Development Officer

Prof. Michael Charles-Ferguson Hannay

Chief Product & Supply Chain Officer

FAQs

What is Bicycle Therapeutics Plc share price today?

Bicycle Therapeutics Plc share price today is $4.31 as on . Bicycle Therapeutics Plc share today touched a day high of $4.5 and a low of $4.25.

What is the 52 week high and 52 week low for Bicycle Therapeutics Plc share?

Bicycle Therapeutics Plc share touched a 52 week high of $9.69 on and a 52 week low of $4.3 on . Bicycle Therapeutics Plc stock price today i.e. is trending at $4.31,which is 55.52% down from its 52 week high and 0.35% up from its 52 week low.

What is Bicycle Therapeutics Plc's market capitalisation today?

Bicycle Therapeutics Plc market capitalisation is $0.00T as on .

How to invest in Bicycle Therapeutics Plc Stock (BCYC) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Bicycle Therapeutics Plc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Bicycle Therapeutics Plc Shares that will get you 0.3480 shares as per Bicycle Therapeutics Plc share price of $4.31 per share as on March 23, 2026 at 7:40 pm IST.

What is the minimum amount required to buy Bicycle Therapeutics Plc Stock (BCYC) from India?

Indian investors can start investing in Bicycle Therapeutics Plc (BCYC) shares with as little as ₹94.058 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹940.58 in Bicycle Therapeutics Plc stock (as per the Rupee-Dollar exchange rate as on ). Based on Bicycle Therapeutics Plc share’s latest price of $4.31 as on March 23, 2026 at 7:40 pm IST, you will get 2.3202 shares of Bicycle Therapeutics Plc. Learn more about fractional shares .

What are the returns that Bicycle Therapeutics Plc has given to Indian investors in the last 5 years?

Bicycle Therapeutics Plc stock has given -82.76% share price returns and 29.13% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?